Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693

Isabelle Flammang; Moritz Reese; Anda J Ströse; Zixuan Yang; Johannes A Eble; Sameer A Dhayat

doi:10.3390/cancers16162825

Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693

Cancers (Basel). 2024 Aug 12;16(16):2825. doi: 10.3390/cancers16162825.

Authors

Isabelle Flammang¹, Moritz Reese¹, Anda J Ströse¹, Zixuan Yang¹, Johannes A Eble², Sameer A Dhayat¹

Affiliations

¹ Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany.
² Department of Physiological Chemistry and Pathobiochemistry, University of Muenster, Waldeyerstrasse 15, 48149 Muenster, Germany.

Abstract

In the original publication [...].

Publication types

Published Erratum

Grants and funding

This research received external funding by the Maria Moeller Stiftung, Muenster, Germany (no Grant Number). Research on exosomal miRNAs as non-invasive biomarkers in PDAC was partly funded by a research grant of the Maria Moeller Stiftung, Muenster, Germany awarded to Anda J. Ströse. The material reflects only the authors’ point of view and funding partners are not liable for any use that may be made of the information contained therein.